thank afternoon you Thanks, and for joining Matt. Good us.
is again healthcare our a diligently through while to we on normalcy. Before a quarter. the the the quarter of where we a first a $XX increase have XX% October revenue of to to the quarter, thank with cautiously third was This total details the community in compared pre-announcement returns revenue in into quarter get take employees history to million, XXXX. I COVID-XX, record essential X, company's continue the third In members who moment time of and the accordance million want of our for exceeded to work world $XX.X
than XX,XXX surgeons X,XXX During more the procedures, by surpassed quarter, we also performed worldwide. iFuse
only also at manage but operating revenue execute high a in reflected growth, our which expenses As organization, an we not losses. ability and to control our level, is continue to
to the surgeon been pandemic, had of eliminates This days the that early rates prior to simulator of the barriers the many platform reduce As impactful and that training we historically the adopt of were COVID-XX SI-BONE the during initiatives most we utilization of has has pandemic. innovative increased the one forced system. surgeon to rollout training overcome cost
medical team and surgeons. now exposure radiation on the lab, for eliminates demand, bypassing affairs our which reps train Our can surgeons cadaver
requirements part no physician Additionally planning. on reps, and the logistical travel of there overall which the are cost significantly and reduces
the driver from a the efficiency While has from perspective, positive positive this the reception key the company, for been surgeon an has been community.
to trained over our combined expect new The Specifically, as and and anatomy XXX surgeons on in well versatility, we trainings the using number well new extremely with well procedures relevant the future. train was we capability quarter received. male ahead is attract female the dysmorphic in ramping the many will which of more this has been surgeon system, capabilities ability of this remarkable expectations, options, several surgeons and feedback
surgeons targeting trained approximately and of completed procedure. a been United which States, the in X,XXX are We X,XXX have
have we a long So way go. to
enthusiastic days surgeons. the effectively which allowed XX trained, with over at our the target it simulators surgeons reengage last to the and has us surgeons be inactive ease can of reception and Given more new
plan we to end simulators result, up of XXXX. add of a As total by the XX to a training
over analysts as adult Whang. attended the might suffering SI webinar from the Clinic; addressed future the Brain from for Orthopedics Dr. course Fusion and Robert the has July, Panorama also the surgeon Medicine; the To-date, William attendees. well the for hold series and Spine additional SI webinar American Society's Dr. featuring Eastlack have have in School joint completed Maryland from Bedrock pandemic. Joint XX notably, we programs Pain, XX hosted of from potential Yale four on and programs invasive the procedure. led Annual Spine; the opportunity what and and XXXX. a well-received conjunction end Health. Tobler program October treat investors planned Peter to with we hosted for The spine and the we the an and Dix X, minimally very education of Meeting, Gary program XXX been diagnosis patients over Spine and Dr. who Spine also Our On panel of highlighted deforming. Dr. Scripps as North Dr. virtual in Mayfield a platform through Desai was over Bharat by of the underpenetrated Brain, Most fusion, The attracting from
total medical We residents have center brings fellows progress centers. This at continued also academic programs and medical [Indiscernible], our and the number training Boston UCSF, of Rush, academic other with University to are residents major XX approximately and trained training important using note of also these now centers to of academic the fellows. It's in resulted over Bedrock. which XX programs that XXX
We are and recently engaging scale the business involving included initiatives also have in purchasing projects which to automation more hiring.
processing accomplished million family Fusion. X.X adopted minimally into -- lives. other the States, the sales as of estimated to will for iFuse-exclusive Joint have of more invasive We where and coverage projects to without the goal has August scale with invasive focus order SI Medica, policy reimbursement of in The us solutions commercial compared is tailwind iFuse company continue the an across XX million exclusive approximately with covered XX the Fusion broad covered a United we in business based products. field coverage management. on not results an data lives. Joint this revenues have Minnesota, turned inventory projects widespread to United largest to to XXXX XXX is for enable minimally iFuse could these payers now with profitability the grow. Overall, for strength one our clinical automated the coverage including leading our Medica an policies efficiently, States of QX in We reimbursement SI On coverage and
us offering million. of the continue believe combined marketable follow-on our focusing October, we to completed from the the this proceeds that $XXX allow We cash securities of in with we quarter had proceeds will a growth. yielding third and at of driving $XX.X sustainable Lastly, offering on net million end
the from U.S. in $XXX Fusion. million payers, billion surgeon expanded in Specifically future. given the XXXX expand as was believe SI payment, private estimate the We year invasive a increase improved minimally position with to over coverage a the be market unique the landscape reimbursement per XX% we're to over the as for well insurance including Joint in we potential market $X little in
train invest As business field and engage process our We in awareness, we Joint invest leverage offerings of deformity profitability. this we initiatives market of be simulators to a plan in to in XXXX. the product current force, sales opportunity and patient initiatives sacroiliac systems beneficiaries market surgeons, in Fusion And and in the to intend trauma to scale expand improvements capture to leader growth will number grow our to expansion. the
of be systematically will will that the be throughout While introduced these to important investments made year. they majority note in XXXX, the it's
revenue As performance COVID-XX In the face continues quarter are remain not the and cautious our conclude, resurgence a we record do to of the growth. on fourth material our of cases. challenges, team operate uncertainty our half normally, and the of flu season surrounding about anticipate result, we but given these having impact second investments COVID-XX XX% To sales XXXX forecast. quarter third with the pleased a revenue we
business in Officer improvements to However, landscape and post-IPO With believe to financial will next will underlying results. now on in the support that we Francis, over in year. results from Laura the more Chief recent Financial call momentum the Operating our carry I Officer business that reimbursement provide into the our our turn and detail our Chief investments